The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Association of the Köbner Phenomenon With Disease Activity and Therapeutic Responsiveness in Vitiligo Vulgaris
Abstract
OBJECTIVE: To investigate the association between the experimentally induced Kobner phenomenon (KP-e) and the Kobner phenomenon by history (KP-h), disease activity, and therapeutic responsiveness in vitiligo vulgaris. DESIGN: Cohort study. SETTING: An outpatient clinic. PATIENTS: Sixty-one consecutive patients with vitiligo vulgaris. INTERVENTION: Three months after a standardized epidermodermal injury was induced, the KP-e was evaluated. For 1 year, UV-B (311 nm) therapy or topical fluticasone propionate plus UV-A therapy was given, depending on the severity of depigmentation. MAIN OUTCOME MEASURES: The presence or absence of the KP-e and the KP-h disease activity as scored on a 6-point scale from -1 to +4 (vitiligo disease activity [VIDA] score) and therapy-induced repigmentation grade. RESULTS: Nineteen (31%) of the patients had a positive KP-h, whereas 37 (61%) showed a positive KP-e (P<.001). The VIDA score did not always predict a positive KP-e, although patients with a positive KP-e had a higher mean VIDA score (VIDA score of 1.6) than did patients with a negative KP-e (VIDA score of 0.5) (P<.001). The responsiveness to UV-B (311 nm) therapy among KP-e-positive or KP-e-negative patients was not significantly different (P=.66). However, KP-e-positive patients who were treated with fluticasone propionate plus UV-A showed a better response than did KP-e-negative patients (P=.01). Among patients responding to both therapies, VIDA scores were significantly decreased (P<.001) compared with VIDA scores before therapy. CONCLUSION: The KP-e may function well as a clinical factor to assess present disease activity and may also predict the responsiveness to fluticasone propionate plus UV-A therapy but not to UV-B (311 nm) therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treatment of Vitiligo With UV-B Radiation vs Topical Psoralen Plus UV-A
Westerhof, W. (1997) · Archives of Dermatology · doi:10.1001/archderm.133.12.1525 · Cited by 370
Self-citationMoellmann, G., Klein-Angerer, S., Scollay, D. A., Nordlund, J. J., & Lerner, A. B. (1982) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12500086 · Cited by 213
Vitiligo and Other Diseases: Coexistence or True Association?
Schallreuter, K. U., Lemke, R., Brandt, O., Schwartz, R., Westhofen, M., Montz, R., & Berger, J. (1994) · Dermatology · doi:10.1159/000247164 · Cited by 186
Clinical features and course of type A and type B vitiligo
Koga, M., & Tango, T. (1988) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1988.tb01778.x · Cited by 146
An epidemiologic case-control study in a population with vitiligo
Barona, M. I., Arrunátegui, A., Rafael Falabella, F., & Alzate, A. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)91282-7 · Cited by 119
Guidelines of care for vitiligo
Task Force (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90691-x · Cited by 93
Guidelines for the Treatment of Vitiligo
Antoniou, C., & Katsambas, A. (1992) · Drugs · doi:10.2165/00003495-199243040-00005 · Cited by 54
Cited by
Ezzedine, K., Lim, H. W., Suzuki, T., Katayama, I., Hamzavi, I., Lan, C. C. E., Goh, B. K., Anbar, T., Silva de Castro, C., Lee, A. Y., et al. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.00997.x · Cited by 702
Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy☆, ☆☆
NJOO, M., BOS, J., & WESTERHOF, W. (2000) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(00)90133-6 · Cited by 331
Self-citationVitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy
Boniface, K., Seneschal, J., Picardo, M., & Taïeb, A. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8622-7 · Cited by 272
A review of melanin sensor devices
Kanellis, V. G. (2019) · Biophysical Reviews · doi:10.1007/s12551-019-00581-8 · Cited by 29
Metadata
- Authors
- Njoo, M. D., Das, P. K., Bos, J. D., & Westerhof, W.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 1999-04-01
- Volume
- 135
- Issue
- 4
- Pages
- 407-13
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W1972518074
- Cited by
- 265
- References
- 7
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association of the Köbner Phenomenon With Disease Activity and Therapeutic Responsiveness in Vitiligo Vulgaris. https://app.cochat.ai/papers/10.1001/archderm.135.4.407
- The paper
- Njoo, M. D., Das, P. K., Bos, J. D., & Westerhof, W. (1999). Association of the Köbner Phenomenon With Disease Activity and Therapeutic Responsiveness in Vitiligo Vulgaris. Archives of Dermatology. https://doi.org/10.1001/archderm.135.4.407
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.